Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)Thomas Cerny, S.B. Kaye, Steven Kaplan et al.|British Journal of Cancer|1994Cited by 161
Docetaxel (Taxotere) in advanced malignant melanoma: a phase II study of the EORTC early clinical trials groupSteinar Aamdal, Jaap Verweij, J. Wanders et al.|European Journal of Cancer|1994Cited by 82
Phase II trial of the oral platinum complex JM216 in non-small-cell lung cancer: An EORTC early clinical studies group investigationIan Judson, A.-R. Hanauske, Steven Kaplan et al.|Annals of Oncology|1997Cited by 54